Serbian Journal of Experimental and Clinical Research

Serbian Journal of Experimental and Clinical Research 由 University of Kragujevac 出版。按 OpenAlex 近年发文统计，该刊主要发表 Antioxidant Activity and Oxidative Stress、Dialysis and Renal Disease Management、Nitric Oxide and Endothelin Effects 等主题的论文，这 3 个主题约占 21%。（根据 OpenAlex 主题统计与中科院分区数据生成）

EABR. Experimental and Applied Biomedical Research former Serbian Journal of Experimental and Clinical Research is a peer-reviewed, open access journal which publishes original research articles, reviews, case reports and letters to the editor in all areas of the biomedical sciences that have not been published previously. The journal comprises both basic and clinical research in the field of biomedicine. Current acceptance rate is around 30%. EABR was founded in 2000 under the name Medicus and over more than two decades has grown into one of the leading national journals in the field of biomedical sciences. EABR. Experimental and Applied Biomedical Research is owned and published by Faculty of Medical Sciences, University of Kragujevac. The journal adheres to the policies of the International Committee of Medical Journal Editors (ICMJE) and publishing ethics guidelines provided by the Committee on Publication Ethics (COPE).EABR publishes papers from all fields of biomedical science and practice in form of original papers, short communications, reviews/meta-analyses, case reports, medical history articles, personal views, letters to the editor, reports from scientific meetings that have not been published previously. EABR is an Open Access Journal and it is published four times a year.The first issue of EABR was published in March 2000.EABR is owned and published by Faculty of Medical Sciences University of Kragujevac. However, Editors have full academic freedom and authority for determining the editorial content of the journal, according to their scientific, professional and ethical judgment.Editorial policy and decision making follow procedures which are endeavoring to ensure scientific credibility of published content, confidentiality and integrity of authors, reviewers, and review process, protection of patients’ rights to privacy and disclosing of conflict of interests.Copyright PolicyThe journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users. All articles published in EABR. Experimental and Applied Biomedical Research are published and distributed under the terms of the CC BY-NC-ND 4.0 License, hich permits reproduction, distribution, derives and commercial use, provided the original work is properly cited and authors and publisher are properly identified. After copyright assignment, copyrights to published articles are transfered tothe owner and publisher of th

摘自期刊官网 Aims & Scope

研究方向（LetPub）：Medicine-Medicine (all)

主编 Olgica Mihaljevic出版商官网

编委会国家分布：未见中国大陆编委；主要国家 塞尔维亚 4、美国 1（共 5 位编委标注了国家） 编委会 ↗出版商官网 · 2026-11-01

中科院期刊分区表

CiteScore 分区（Scopus，2026 年 6 月版）

Scopus 按 CiteScore 在每个学科内为期刊排名，百分位 75 及以上为 Q1，每 25 为一档；与中科院分区是不同体系。LetPub

数据库收录

ScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

CiteScore 2026-06

0.6LetPub · 2026-11-01

CiteScore（出版商公布）

0.6出版商官网 · 2026-11-01

SJR 2026-06

0.12LetPub · 2026-11-01

SNIP 2026-06

0.14LetPub · 2026-11-01

h-index

15OpenAlex · 2026-11-01

i10-index

38OpenAlex · 2026-11-01

两年平均被引

0OpenAlex · 2026-11-01

Gold OA 文章占比

0%LetPub · 2026-11-01

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

平均审稿速度（社区反馈）

6 WeeksLetPub · 2026-11-01

录用率（出版商公布）

30%出版商官网 · 2026-11-01

评审方式

双盲同行评审LetPub

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

University of Kragujevac

出版国家或地区

Poland

出版语言

English

ISSN

1820-8665

印刷版 ISSN

2956-0454

电子版 ISSN

2956-2090

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 作者指南 ↗LetPub
• Aims & Scope ↗LetPub
• 专刊 / 特刊征稿 ↗出版商官网
• 评审流程 ↗LetPub
• 编委会 ↗LetPub